Neoadjuvant Chemotherapy Cannot Be Regarded as Adequate Routine Therapy Strategy of Advanced Ovarian Cancer

Minority vote to statement A5 of the Fourth Ovarian Cancer Consensus Conference, Vancouver 2010, on behalf of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) Study Group Germany plus North-Eastern Society of Gyneco-Oncology and the AGO Austria.

Saved in:
Bibliographic Details
Published inInternational journal of gynecological cancer Vol. 22; no. 2; pp. 182 - 185
Main Authors Andreas du Bois, Marth, Christian, Pfisterer, Jacobus, Harter, Philipp, Hilpert, Felix, Zeimet, Alain G, Sehouli, Jalid
Format Journal Article
LanguageEnglish
Published Kidlington Elsevier Limited 01.02.2012
Subjects
Ovarian cancer
Online AccessGet full text
ISSN1048-891X
1525-1438
DOI10.1136/ijgc-00009577-201202000-00005

Cover

More Information
Summary:Minority vote to statement A5 of the Fourth Ovarian Cancer Consensus Conference, Vancouver 2010, on behalf of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) Study Group Germany plus North-Eastern Society of Gyneco-Oncology and the AGO Austria.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ISSN:1048-891X
1525-1438
DOI:10.1136/ijgc-00009577-201202000-00005